Record full-year total revenue and AVISE® CTD average selling price New biomarkers and sales force expansion drove over 11% full-year test volume ...

TIC Solutions, Inc. (NYSE: TIC) ("TIC Solutions" or the "Company"), a leading provider of tech-enabled Testing, Inspection, ...

Tempus AI, Inc. Class A ((TEM)) has held its Q4 earnings call. Read on for the main highlights of the call. Tempus AI, Inc. used its latest earnings call to underscore a broadly upbeat outlook, ...

Net loss was $50.0 million in the fourth quarter of 2025, or $1.20 per diluted share, compared to a net loss of $1.3 million, or $0.03 per diluted share, in the prior year period. The reduction was ...

Q4 2025 Earnings Call March 4, 2026 4:30 PM ESTCompany ParticipantsDavid Deuchler - Managing DirectorOguzhan Atay - ...

No revenue was recognized in Q4 from products currently under NPD, as these remain in the development phase. Kirsten Newquist ...

MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF) announces a brokered private placement offering of up to $20 million to advance natural hydrogen exploration in Saskatchewan and critical minerals ...

Q4 2025 Earnings Call March 16, 2026 8:00 AM EDTCompany ParticipantsKristal Li - Investor Relations ManagerYan Li - Chairman, ...

In 2025, Zen Technologies launched new products in collaboration with Ai Turing Technologies, which enhance anti-drone systems. This has the potential of becoming the third revenue stream for the ...

Caris Life Sciences®, Inc. (NASDAQ: CAI), a leading, patient centric, next-generation AI TechBio company and precision medicine pioneer, today reported financial results for the quarter and full year ...

Generated record revenue of approximately $120 million for full-year 2025, driven by PAC performance Reported Adjusted EBITDA(1) of $13 million, representing 26% improvement year-over-year Provided ...

ConfirmMDx: An epigenetic test used to help identify patients at increased risk for aggressive prostate cancer following a ...